Ketamine, Esketamine and Depression

In October 2019, the U.S. Food and Drug Administration (FDA) approved esketamine, a substance chemicallyrelated to the party drug ketamine, as a nasal spray to treat depression (Bahr, 2019). The effectiveness of ketamine for depression was first shown in studies in...

The Anti-Anxiety Diet: What It Is and How It Helps

Over the past three decades, complementary and alternative medicine (CAM) has become increasingly popular. For people with anxiety, complementary health approaches (CHAs) have become a viable option.  In the treatment of anxiety disorders, the goal of CAM is to...